Skip to content

Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) The large trial to improve the medical care of the family doctors for type 2 diabetes patients and to decrease dropout rate of these patients.

Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) The large trial to improve the medical care of the family doctors for type 2 diabetes patients and to decrease dropout rate of these patients. - Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000002186
Enrollment
3750
Registered
2009-07-13
Start date
2009-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

1) Encourage the patients for regural checkups. 2)Patient education 3)Feedback of evaluatoion of doctor&#39
s patient care to these doctors and bench-marking. Usual medical care

Sponsors

Japan Foundation for the Promotion of International Medical Research Cooperation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 2 diabetes patient diagnosed as below criteria 1) The patient satisfying criteria of Japan diabetes society 2) The patient diagnosed as diabetes mellitus in another hospital 3) The patient undergoing treatment by diabetes remedy (oral hypoglycemic agent, insulin)

Exclusion criteria

Exclusion criteria: 1) The patient under hemodialysis 2) The patient who are admitted to the hospital 3) The bedridden patient or the practically bedridden patient 4) The patients who are resident in nursing homes 5) The patient with medical history of Blindness or leg amputation 6) The patient diagnosed as malignant disease in the last five years 7) The pregnant patient or the possible pregnant patient 8) The patients who are regularly followed for diabetes mellitus by two or more medical institutions (except for treatment of complication) 9) Type 1 diabetes mellitus or possible type 1 diabetes patient

Design outcomes

Primary

MeasureTime frame
Dropout rate of outpatients

Countries

Japan

Contacts

Public ContactKatsuya Yamazaki

University of Toyama Faculty of Medicine, Internal Medicine 1

kyamazak@med.u-toyama.ac.jp076-434-7287

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026